News

Voranigo® Celebrates Multi-Regional Prix Galien Triumphs

Voranigo® Celebrates Multi-Regional Prix Galien Triumphs

Voranigo® Recognized with Multiple Prix Galien Awards

Servier's Voranigo® (vorasidenib) has recently achieved remarkable recognition by winning the prestigious Prix Galien Awards in various regions. This acknowledgment serves as a testament to the significant strides made by Voranigo® in benefiting patients diagnosed with glioma. The awards include the Prix Galien USA, the Prix Galien Poland, and the Prix Galien Bridges Awards, all primarily focusing on Best Product for Orphan/Rare Diseases.

Acknowledgment for Innovative Advancements

The Prix Galien Awards highlight innovative advancements within the healthcare sector, specifically recognizing breakthrough products and exceptional research teams in pharmaceutical, biotech, medtech, and digital health arenas. With several awards under its belt, Voranigo® is paving the way for enhanced treatment options for glioma patients worldwide.

2025 Prix Galien Bridges Award

During a recent awards ceremony held in Stockholm, Voranigo® was honored with the inaugural 2025 Prix Galien Bridges Award for Best Product for Orphan/Rare Diseases. This award showcases the commitment that Servier has towards fostering life science innovation across multiple regions, including the Nordic countries and key biopharmaceutical communities from Europe and the Middle East.

Recognition in the USA and Poland

In addition to the Bridges Award, Voranigo® has also been bestowed with the highly esteemed Prix Galien USA Award and the Prix Galien Poland Award in the Best Product category for Orphan/Rare Diseases. These recognitions not only celebrate Servier's dedication to innovation but also validate the potential impact Voranigo® is set to have on patient care.

Commitment to Patients and Innovation

Arnaud Lallouette, Executive Vice-President of Global Medical & Patient Affairs at Servier, expressed gratitude for these accolades, emphasizing their significance in recognizing the scientific advancements Voranigo® brings to glioma patients. Lallouette stated, "We are truly honored to receive these prestigious distinctions in several countries. It recognizes the scientific progress that Voranigo® can bring to patients living with glioma across the world. It rewards Servier's commitment to innovation and to patients as we continue to advance precision oncology for all who stand to benefit."

Clinical Significance of Voranigo®

Voranigo® has received marketing authorization to treat predominantly non-enhancing Grade 2 astrocytoma or oligodendroglioma cases associated with specific mutations in adults and adolescents aged 12 years and older. Particularly, it targets individuals diagnosed with an isocitrate dehydrogenase-1 (IDH1) R132 or isocitrate dehydrogenase-2 (IDH2) R172 mutation, provided they weigh at least 40 kg and are not requiring immediate radiotherapy or chemotherapy after surgical interventions.

About Servier

Servier is recognized as an independent international pharmaceutical company dedicated to delivering innovative treatment solutions. As they continue to make strides in oncology and various other therapeutic areas, they remain committed to fostering a healthier future for patients globally. As part of their outreach, Servier encourages following their developments and updates through their official social media platforms.

Frequently Asked Questions

What is Voranigo® and what condition does it treat?

Voranigo® (vorasidenib) is an innovative treatment primarily used for adults and adolescents with specific genetic mutations associated with low-grade gliomas.

Which awards has Voranigo® recently received?

Voranigo® has won the Prix Galien USA, Prix Galien Poland, and the Prix Galien Bridges Awards for its exceptional performance in treating orphan/rare diseases.

What does the Prix Galien Award signify?

The Prix Galien Award is a prestigious accolade that honors significant innovations in the life sciences field, recognizing breakthrough products and outstanding research teams.

Who is Servier?

Servier is an independent international pharmaceutical group committed to providing innovative healthcare solutions and improving patient outcomes through advanced medical research.

What is the significance of the Prix Galien Bridges Award?

The Prix Galien Bridges Award highlights the innovation in life sciences, especially recognizing contributions within the Nordic countries and their connection to key biopharmaceutical sectors in Europe and the Middle East.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 3

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Omneky Integrates AI Growth Agent With Slack for Ads

Updated Category News Views 2

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 5

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 5

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 3

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 5

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Linkind's Light Stick Revolutionizes Retail Lighting Experience

Updated Category News Views 4

Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of America Announces Dividends for Shareholders in 2025

Updated Category News Views 794

Bank of America Declares Second Quarter Stock Dividends Bank of America Corporation has made an important announcement regarding its regular quarterly cash dividends on its common stock. The Board of Directors has declared a dividend of $0.26 per share, which will be paid to shareholders of record. Dividend Details for Shareholders This dividend is scheduled for payment...

Continue Reading
Delta Air Lines' Earnings Miss Expectations Amid Market Movements

Updated Category News Views 69

Delta Air Lines and Market Overview U.S. stock markets appeared somewhat mixed during the trading day as investors digested various earnings reports and economic indicators. Notably, the Nasdaq Composite edged up slightly by 0.1% recently, reflecting the ongoing fluctuations in market sentiments. Current Market Performance The Dow Jones fell by 0.17%, settling at...

Continue Reading
Aegon Announces Shawn C.D. Johnson as New CEO of Aegon AM

Updated Category News Views 238

Aegon Appoints Shawn C.D. Johnson as CEO of Aegon Asset Management Aegon has officially announced the appointment of Shawn C.D. Johnson as the new CEO of Aegon Asset Management (Aegon AM) and as a member of Aegon’s Executive Committee. Shawn takes over from Bas NieuweWeme, who has chosen to explore new career opportunities outside of Aegon. To facilitate a smooth...

Continue Reading
Companies Set to Announce Earnings This Friday

Updated Category News Views 67

Upcoming Earnings Reports We are entering earnings season, an important period for both investors and analysts. This Friday, several prominent companies are set to announce their financial results. Notable names include Brady Corp, ABM Industries (NYSE: ABM), and BRP (NASDAQ: DOOO) Inc, all of which will report before the market opens. Anticipation for Morning Earnings As...

Continue Reading
Heineken Unveils 'Off Socials' Campaign Featuring Joe Jonas

Updated Category News Views 392

Heineken's New Campaign Focuses on Real Connections Global superstar Joe Jonas has teamed up with popular influencers to promote Heineken's campaign titled #SocialOffSocials. At a recent exclusive event, they emphasized the importance of connecting with others in real life, aiming to combat the challenges of digital overload. Jonas, alongside notable figures like Seth...

Continue Reading